next generation ulcerative colitis drugs (Actavis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenext generation ulcerative colitis drugs (Actavis)
Drug Alias Namenext generation ulcerative colitis drugs (Warner Chilcott)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Pharmaceuticals Ireland Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan PlcAllergan Pharmaceuticals Ireland Ltd
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A